Cargando…
LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
BACKGROUND: Mantle cell lymphoma (MCL) is considered an aggressive subtype of non-Hodgkin’s lymphoma with variable treatment responses. There is an urgent need to identify novel markers with prognostic and therapeutic value for MCL. Long non-coding RNAs (lncRNAs) have emerged as key regulators in ca...
Autores principales: | Wang, Xin, Sehgal, Lalit, Jain, Neeraj, Khashab, Tamer, Mathur, Rohit, Samaniego, Felipe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175387/ https://www.ncbi.nlm.nih.gov/pubmed/27998273 http://dx.doi.org/10.1186/s12967-016-1100-9 |
Ejemplares similares
-
Targeting Wnt pathway in mantle cell lymphoma-initiating cells
por: Mathur, Rohit, et al.
Publicado: (2015) -
LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer
por: Wang, Dejie, et al.
Publicado: (2015) -
TRA2A Binds With LncRNA MALAT1 To Promote Esophageal Cancer Progression By Regulating EZH2/β-catenin Pathway
por: Zhao, Xing, et al.
Publicado: (2021) -
lncRNA MALAT1 promotes cell proliferation and invasion by regulating the miR-101/EZH2 axis in oral squamous cell carcinoma
por: Xiao, Lei, et al.
Publicado: (2020) -
Inhibition of Methyltransferases Accelerates Degradation of cFLIP and Sensitizes B-Cell Lymphoma Cells to TRAIL-Induced Apoptosis
por: Braun, Frank K., et al.
Publicado: (2015)